ChemMedChem
Scope & Guideline
Pioneering insights for the next generation of pharmaceuticals.
Introduction
Aims and Scopes
- Medicinal Chemistry and Drug Design:
The core focus is on the design, synthesis, and evaluation of new chemical entities with potential therapeutic applications, particularly in oncology, infectious diseases, and metabolic disorders. - Biological Evaluation and Mechanistic Studies:
Research often includes evaluation of biological activities of compounds, exploring mechanisms of action, and understanding structure-activity relationships (SAR) to optimize therapeutic efficacy. - Nanomedicine and Drug Delivery:
The journal publishes studies on novel drug delivery systems, including nanoparticles and nanocarriers, aimed at enhancing the bioavailability and targeted delivery of therapeutic agents. - Natural Products and Synthetic Derivatives:
Research related to the isolation, modification, and pharmacological evaluation of natural products and their synthetic derivatives is a prominent theme, highlighting their potential as drug candidates. - Chemical Biology and Target Identification:
ChemMedChem includes work on the application of chemical tools to elucidate biological pathways, identify drug targets, and develop new therapeutic strategies. - Innovative Analytical Techniques:
The journal encourages the use of advanced analytical techniques such as molecular modeling, high-throughput screening, and various spectroscopic methods to aid drug discovery.
Trending and Emerging
- Targeted Therapy and Precision Medicine:
Recent publications highlight a growing interest in targeted therapies and precision medicine approaches, focusing on personalized treatment options based on genetic and biomolecular profiling. - Proteomics and Targeted Protein Degradation:
The use of proteomics to identify new drug targets and the development of PROTACs (Proteolysis Targeting Chimeras) for targeted protein degradation are gaining traction, showcasing innovative strategies for drug discovery. - Drug Repurposing Strategies:
There is an increasing trend towards drug repurposing, particularly in the context of emerging diseases such as COVID-19, where existing drugs are evaluated for new therapeutic applications. - Nanotechnology in Therapeutics:
The integration of nanotechnology in drug delivery systems, including the use of nanomaterials for enhanced therapeutic efficacy and imaging, is a rapidly expanding area of interest. - Artificial Intelligence and Machine Learning in Drug Discovery:
The application of AI and machine learning techniques for predictive modeling, compound screening, and optimizing drug design processes is becoming increasingly prominent in recent publications. - Hybrid Molecules and Multitarget Agents:
Research on hybrid molecules that combine multiple pharmacophores or target multiple pathways is on the rise, reflecting a shift towards more complex and effective therapeutic agents.
Declining or Waning
- Traditional Small Molecule Antibiotics:
Research on traditional small molecule antibiotics has decreased, possibly due to a shift towards exploring novel mechanisms of action and the use of combination therapies to combat antibiotic resistance. - Single-Target Therapeutics:
The focus on single-target drug design has waned in favor of multitarget approaches, reflecting a growing understanding of the complexity of diseases and the need for holistic treatment strategies. - In vitro Studies without in vivo Validation:
There is a noticeable decline in standalone in vitro studies that lack in vivo validation, as the field increasingly emphasizes translational research that bridges laboratory findings with clinical relevance. - Basic Chemistry without Biological Context:
Papers that focus purely on synthetic methodologies without direct applications in medicinal chemistry or biological evaluation have seen a reduction, as the journal prioritizes research with clear therapeutic implications.
Similar Journals
ACTA PHARMACEUTICA
Connecting scholars and practitioners with cutting-edge insights.ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.
BIOORGANIC CHEMISTRY
Unveiling the synergy between chemistry and biology.BIOORGANIC CHEMISTRY, published by Academic Press Inc., a prestigious imprint of Elsevier Science, represents a cornerstone in the fields of biochemistry, organic chemistry, and drug discovery. With an impressive Scopus rank placing it in the top quartiles across critical categories—including Q2 for Biochemistry and Drug Discovery, and Q1 for Organic Chemistry—this journal has established itself as a vital resource for researchers, professionals, and students alike. Featuring a diverse array of articles that explore innovative methodologies and emerging trends from 1971 to the present, BIOORGANIC CHEMISTRY effectively bridges the gap between laboratory research and practical applications. Although not an Open Access journal, its rigorous peer-review process ensures the delivery of high-quality, impactful research that drives advances in the understanding and application of biochemistry. With an aim to facilitate scientific discourse and collaboration, it invites contributions that further the exploration of chemical processes within biological systems.
CHEMISTRY LETTERS
Bridging theory and practice in chemistry.Chemistry Letters, published by the Chemical Society of Japan, is a distinguished academic journal that focuses on pivotal developments in the field of chemistry. Since its inception in 1973, the journal has been a vital platform for the dissemination of novel research findings across various sub-disciplines, encompassing both theoretical advancements and practical applications. As a testament to its significance in the community, Chemistry Letters has achieved a Category Quartile of Q2 in the 2023 ranking for miscellaneous Chemistry journals, reflecting its respected position among peers. Although it does not offer Open Access, the journal remains accessible through institutional subscriptions, thus ensuring a wide reach for its valuable content. With an active scope ranging from general chemistry topics to specialized studies, it is ideal for researchers, professionals, and students alike who seek to contribute to and expand their knowledge within this dynamic field. The journal continuously aims to promote excellence in chemical research, facilitating dialogue and collaboration among chemists worldwide.
MOLECULAR DIVERSITY
Advancing Interdisciplinary Research in Chemistry and BiologyMOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.
TETRAHEDRON LETTERS
Advancing the Frontiers of Chemical KnowledgeTETRAHEDRON LETTERS, published by Pergamon-Elsevier Science Ltd, is a leading journal in the fields of Biochemistry, Drug Discovery, and Organic Chemistry, with a rich legacy since its inception in 1959. This prestigious journal serves as a vital resource for researchers and professionals dedicated to advancing the understanding of chemical sciences, featuring high-impact research that influences both academic and practical applications. Although it is currently classified in the third quartile across its categories for 2023, its rigorous peer-review process ensures the publication of quality research that contributes to the scientific community. With an ISSN of 0040-4039 and an E-ISSN of 1873-3581, TETRAHEDRON LETTERS is easily accessible for those in the academic landscape seeking to stay abreast of innovative developments. Researchers, professionals, and students alike will find invaluable insights and collaborative opportunities within the pages of TETRAHEDRON LETTERS, making it an essential read for anyone involved in the chemical sciences.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Transforming Discoveries into Therapeutic SolutionsJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Shaping Therapeutic Strategies with High-Quality Research.European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.
Future Medicinal Chemistry
Shaping the future of pharmacology and molecular medicine.Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.
CHEMICAL & PHARMACEUTICAL BULLETIN
Pioneering research for a healthier tomorrow.CHEMICAL & PHARMACEUTICAL BULLETIN, published by the Pharmaceutical Society of Japan, has been a cornerstone in the fields of chemistry, drug discovery, and medicine since its inception in 1958. With an ISSN of 0009-2363, this esteemed journal offers a platform for the dissemination of innovative research and critical insights contributing to these dynamic disciplines. Housed in Tokyo, Japan, it is strategically poised to bridge the gap between chemical sciences and pharmaceutical applications. Although the journal operates under a traditional subscription model and does not currently offer open access, it maintains a solid reputation, evidenced by its Q3 category rankings in multiple relevant fields and its percentile positions in Scopus, specifically 48th in General Chemistry and 30th in Drug Discovery. Researchers, professionals, and students alike will find invaluable resources within its pages, as it diligently covers shifting paradigms and emerging methodologies critical to advancing both theoretical understanding and practical applications in the pharmaceutical realm.
BIOORGANIC & MEDICINAL CHEMISTRY
Innovating Drug Discovery Through ChemistryBIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.